Subscribe To

Price Alert Latest News Economic Calendar News

AWH / Aspira Women's Health Inc. (AWH) Q4 2022 Earnings Call Transcript

Aspira Women's Health Inc. (NASDAQ:AWH ) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Nicole Sandford - President & Chief Executive Officer Ryan Phan - Chief Scientific Officer & Chief Operating Officer Marlene McLennan - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Griffin Soriano - William Blair Operator Good morning ladies and gentlemen and welcome to Aspira Women's Health, Inc. Fourth Quarter and Year-End 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. Read More

Demo Live Account See Partner Details

Content Topics

Aspira

Women

Health

Inc

AWH

2022

Earnings

Call

Women s

Transcript

Stock

Posted: Mar 22 2023, 22:49

Author Name: Seeking Alpha

AWH News

By GlobeNewsWire
September 29, 2023

Aspira Women's Health to Present at the BioVenture Nexus Conference

The conference is taking place on October 5-6, 2023, in Los Angeles, CA The conference is taking place on October 5-6, 2023, in Los Angeles, CA

By Zacks Investment Research
September 14, 2023

Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?

Here is how Aspira (AWH) and Compugen (CGEN) have performed compared to their sector so far this year.

By Zacks Investment Research
September 12, 2023

All You Need to Know About Aspira (AWH) Rating Upgrade to Buy

Aspira (AWH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stoc

By InvestorPlace
September 3, 2023

Eleventh-Hour Climbers: 7 Stocks Gearing Up for a Late Summer Surge

While some publicly traded enterprises left no doubt as to their trajectory, a few others are just now benefiting from a late summer stock surge. Bett

By Seeking Alpha
August 14, 2023

Aspira Women's Health Inc. (AWH) Q2 2023 Earnings Call Transcript

Aspira Women's Health Inc. (NASDAQ:AWH ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Nicole Sandford – Presiden

By GlobeNewsWire
May 19, 2023

Aspira Women's Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference

AUSTIN, Texas, May 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company

By Zacks Investment Research
May 11, 2023

Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates

Aspira (AWH) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.08

By Zacks Investment Research
March 27, 2023

What Makes Aspira (AWH) a New Buy Stock

Aspira (AWH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.